Small and medium pharmaceutical companies to present significant opportunities for investment in the global cloud-based drug discovery platform market

Among the various end users of cloud-based drug discovery platforms, pharmaceutical vendors are likely to be major stakeholders holding a high value share of the global cloud-based drug discovery platform market. An opportunity analysis of the global market reveals that leading software vendors have already adopted cloud-based drug discovery platforms to facilitate seamless research and development processes. As there is less adoption of these cloud-based platforms in several countries of the MEA, public and private ventures are taking initiatives to invest in the R&D process in this region. Moreover, the MEA cloud-based drug discovery platform revolution will witness significant growth in the coming years, thereby creating better opportunities for software vendors for growth and expansion.

Pharmaceutical Vendors segment to lead the global market in terms of revenue share throughout the forecast period

Our forecasts indicate that the Pharmaceutical Vendors segment will remain the leading end user segment during the forecast period 2017 to 2025, estimated to reach a market valuation of US$ 1,625.0 Mn by the end of the forecast period in 2025, with a CAGR of 13.4%. In terms of CAGR though, the Contract Research Organizations segment is expected to stand first, registering a growth rate of 13.8% during the eight year period. The Contract Research Organizations segment is also anticipated to witness high Y-o-Y growth rates throughout the forecast period.

Request for Report Sample@ https://www.persistencemarketresearch.com/samples/11020

Global Cloud-based Drug Discovery Platform Market: Forecast by End User

The global cloud-based drug discovery platform market is segmented on the basis of end user into Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations, and Others. Pharmaceutical Vendors is expected to be the largest segment in terms of revenue, with a CAGR of 13.4%. Biotech Vendors is the second largest segment in terms of value, estimated to reach a market valuation of US$ 1,247.8 Mn by the end of 2025.

Global Cloud-based Drug Discovery Platform Market: Forecast by Region

Persistence Market Research tracks the performance of the global cloud-based drug discovery platform market across the key regions of North America, Latin America, Europe, Asia Pacific, and MEA. In terms of value, North America is projected to be the most attractive market in the global cloud-based drug discovery platform market during the forecast period. The North America regional market for cloud-based drug discovery platforms is estimated to hold more than 35% value share by the end of the forecast period in 2025. However, the market in APAC is expected to register high Y-o-Y growth rates throughout the forecast period. In terms of value, the APAC cloud-based drug discovery platform market is expected to expand at a CAGR of 16.7% during the forecast period.

Request for Report Table of Content (TOC) @ https://www.persistencemarketresearch.com/methodology/11020

Global Cloud-based Drug Discovery Platform Market: Key Players

Some of the top companies operating in the global cloud-based drug discovery platform market are profiled in the report. Key market players include IBM Corporation, Accenture PLC, Tata Consultancy Services Limited, SAS Institute Inc., BioXcel Corporation, Cloud Pharmaceuticals Inc., WuXi AppTec (Sanghai) Co. Ltd., Dassault System, Acelot, Inc.